Professional Documents
Culture Documents
肌酐分布的文章 2
肌酐分布的文章 2
HUMAN BLOOD
BY BENJAMIN F. MILLER AND RENE DUBOS
(From the Hospital of The Rockefeller fnstitute for Medical Research, New
York)
Methods
Blood and spinal fluid samples were obtained from normal, adult males. Most
of the observations were made upon tungstic acid filtrates prepared according to
the method of Wu (1922). Plasma samples were obtained
from oxalated blood. In the few instances in which spinal fluids were used
they were diluted with water or physiological saline.
An excess of the NC or HR enzyme was added to 10 cc. of the blood fil-trate or
spinal fluid containing 0.5 cc. of M phosphate buffer, pH 7.0 (made according to
Green (1933)). The requisite amount of cells was suspended
in 1 to 2 cc. of Hz0 or 0.9 per cent NaCl solution. The strength of the
enzyme preparation had been determined by the titration previously de-
cribed by Dubos and Miller (1937). The mixture was incubated in 125 cc.
nstoppered flasks at 37” for 30 to 90 minutes, the exact time depending
pon the strength of the enzyme preparation. The cells were removed by
centrifugation at high speed. To 8 cc. of the supernatant fluid were added 4 cc. of
alkaline picrate, and the resultant color was read after 10 minutes.
450 Creatinine in Blood
The analyses were all performed in a Zeiss Pulfrich stufenphotometer, with a
stratum thickness of 30 mm. and the 550 light filter. A control solution of water,
buffer, and enzyme was incubated, centrifuged, and treated with
the alkaline picrate. This served as the balancing solution in the stufen-photometer
to compensate for any turbidity and for the absorption of light
by the alkaline picrate reagent. The residual chromogenic substance was
determined as its creatinine equivalent from a calibration chart, and com-pared
with the value obtained for the total creatinine equivalent of the
original solution. (Further details regarding technique and accuracy of the
method are given in the subsequent paper.)
TABLE I
Amounts of Chromogenic Material Decomposed by Enzymes* in Serum,
Plasma, Erythrocytes, and Spinal Fluid from Normal Individuals
No. of
A-y
Material ,ietermi- chromo-
nations genie
material
--
?% 2
Serum or plasma. ................. 15 1.09
Erythrocytes ...................... 6 1.80
Spinal fluid. ...................... 2 1.11
Results
Filtrates of Serum and Plasma-Filtrates of normal human serum and
plasma were studied according to this technique. Most of the
determinations were made with NC enzyme prepa-rations, and a-smaller
number with HR cell suspensions. Table I indicates that an average of 91
per cent of the chromogenic material originally present was decomposed
by the enzymes. (The details of these analyses and those for the other
fluids are recorded in the following paper.)
Filtrates of Erythrocytes-In filtrates of erythrocytes there was an
average of 40 per cent decomposition of the original chromo-genic
material (Table I). When cells and plasma from the same blood were
analyzed, it was found that the amount of the cellular chromogenic
substance decomposed was equivalent to about three-fourths of that in
the plasma. This represents the same
R, F. Miller and R. Dubos 451
ratio as that which would be calculated from the distribution of
water between cells and plasma (Van Slyke et al. (1925)).
Spinal Fluids-Since only small amounts of spinal fluids were
available, six to eight samples were pooled and analyzed. Table I shows
that the chromogenic material in these representative samples was as
readily decomposed by each of the enzyme prepa-rations (100 per cent!
in the two pooled samples available) as the material in plasma and
serum filtrates.
TABLE II
Concentrations Equivalent to CTeatinine Obtained by Piuric Aoid and
DinitTo-benzoic Acid Methods with Various Compounds Closely
Related to CTeatinine
Concentration e uivalent to
creatinine divide % by concon-
t&ion of compound
Compound -
I Xnitrobeneoio
acid method
Methods
The materials and fiNrates were obtained and prepared as described in the
previous section.
The method described by Langley and Evans was followed, including the
Creatinine in Blood
use of the purified dinitrobenzoic acid reagent. However, a Zeiss Pu&-ich
stujenpholomeler WQSemployed in place of acolorimeler. The stufenphotom-etcr was
calibrated with pure creatinine solutions containing O.CK.lO25mg. to 0.005 mg. per cc.
When’the 30 mm. cups and the S50 light filter of the instrument were employed,
excellent checks for duplicate analyses could be
obtained in this range of creatinine concentration. The results conform
withthe Lambert-Beer law in this range, but not at higher concentrations. The
creatinine equivalents of glycocyamidine, 5-methylglycocyamidine,
and other related compounds were obtained by both the dinitrobenzoic acid
TABLE III
Valuesfor Crealinine Equivalent of Chomogenic Material inPlasma Pillrates
Obtained from Simultaneous Analyses by Alkaline Picrate and Dinitro-
benzoic Acid Melhods (Mg. per 100 Cc. of Original Fluid)
- -
ld5-tungBtat.~teS~anolvlcrlllnlpraated.
It Crentinine
concentmtion
Sample I(,ydinitroben-
zoate method
-- -I-
and picric acid reagents. The results are given in Table II. They
demonstrate
in almost every case that creatinine may be distinguished
from related chromogenic compounds more specifically by means of the dinitro-
benzoic acid method. Similar results with pure solutions were obtained
byBenedictandBehre.
Analysts by the two methods have been performed simultan-eously on the
chromogenic material of plasma and serum filkatcs and other fluids. The
analytical results are compared in Table
III. It is shown that in every sample the two values for the creatininc
equivalent of the chromogenic material agree very closely.
B. F. Miller and R. Dubos
DISCUSSION
Behre, J. A., and Benedict, S. R., J. Biol. Chem., 62, 11 (1922); 117, 415 (1937).
Benedict, S. R., and Behre, J. A., J. Biol. Chem., 114,616 (1936).
Bohn, H., and Hahn, F., 2. klin. Med., 126,468 (1933).
Bolliger, A., Med. J. Australia, 2,818 (1936).
Danielson, I. S., J. Biol. Chem., 113, 181 (1936).
Dubos, R., and Miller, B. F., J. Biol. Chem., 121,429 (1937).
Creatinine in Blood
Ferro-Luzzi, G., Biochem. Z., 276,422 (1935).
Folin, O., J. Biol. Chem., 17,475 (1914).
Gaebler, 0. H., J. Biol. Chem., 89,454 (1930); 117, 397 (1937).
Goudsmit, A., Jr., J. Bid. Chem., 116,613 (1936).
Green, A. A., J. Am. Chem.Sot., 66,233l (1933).
Hayman, J. M., Jr., Johnston, S. M., and Bender, J. A., J. Biol. Chem., 108, 675
(1935).
Hunter, A., and Campbell, W. R., J. BioZ. Chem., 32, 195 (1917).
Langley, W. D., and Evans, M., J. BioZ. Chem., 116, 333 (1936).
Shaffer, P. A., and Reinoso, E. A., Proc. Am. Sot. BioZ. Chem., 1, 30 (1999) (J.
BioZ. Chem., 7 (1909-10)).
Van Slyke, D. D., Hastings, A. B., Murray, C. D., and Sendroy, J., Jr., J. BioZ.
Chem., 66,701 (1925).
Van Slyke, D. D., Hiller, A., and Miller, B. F., Am. J. Physiol., 113, 629 (1935).
Wu, H., J. BioZ. Chem., 61,21 (1922).
Zacherl, M. K., and Lieb, H., 2. physiol. Chem., 226,130 (1934).